Press Release

Acute Myeloid Leukemia Treatment Market to Rise Significantly; Product Launches by Pharmaceuticals Companies Will Aid Growth, Says Fortune Business Insights

Acute Myeloid Leukemia Treatment Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027, Increasing cases of genetic mutations are creating growth opportunities for the global “acute myeloid leukemia treatment“ market says fortune business Insights in a report, titled “Acute Myeloid Leukemia Treatment Market Size, Share and Global Trend By Disease Type (Myeloblastic, Promyelocytic, Myelomonocytic), By Treatment Type (Chemotherapy, Targeted Therapy, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast Till 2026.” Increasing investments in research and development by pharmaceuticals companies are driving the global acute myeloid leukemia treatment market

Request a Sample Copy of the Research Report:

Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global market and discusses how major companies are coping with this.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.


Astellas Pharma Inc., a Japanese pharmaceutical company launched XOSPATA®, for the treatment of relapsed or refractory acute myeloid leukemia in adult patients. The new drug is FDA approved and will support in the treatment of patients with refractory or relapsed FLT3 mutation-positive (FLT3mut+) acute myeloid leukemia. The acute myeloid leukemia treatment market is predicted to witness high demand during the forecast period, owing to the launch of the advanced drug XOSPATA®. Several market players are launching drugs with FDA approval for the treatment of acute myeloid leukemia. For instance, Genentech, Inc. received FDA approval for the Venclexta for the treatment of patients who are newly-diagnosed with acute myeloid leukemia or patients who are not eligible for intensive induction chemotherapy. The aforementioned factors are contributing significantly to the global acute myeloid leukemia treatment market.

Increasing R&D Investments Toto Contribute Growth 

The growingIncreasing cases of acute myeloid leukemia and unmet needs of patients, especially in emerging nations are leading towards the development ofencouraging the discovery of novel new drugs by pharmaceutical companies, which in turn is fostering the enabling growth of in the acute myeloid leukemia treatment market. Ffor instance, Pfizer Inc. launched Cglasdegib (Daurismo) with FDA approval, for patients who are newly-diagnosed with acute myeloid leukemia (AML). In 2019, according to the American Cancer Society, the number of new acute myeloid leukemia cases in the U.S estimated to be 21,450. The rising prevalence of genetic mutation, high exposure to radiations and sedentary lifestyles are some of the factors encouraging the cases of acute myeloid leukemia across the globe. In addition, product launches and rising investments in research and development activities by pharmaceutical companies are also predicted to foster growth for the global acute myeloid leukemia treatment market in the forthcoming year. Nonetheless, high risks of side effects associated with the use of drugs and expensive cost of stem cell transplantation are the factors restraining the growth of the global acute myeloid leukemia treatment market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

For More Information :

 Leading Players operating in the Acute Myeloid Leukemia Treatment Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Genzyme Corporation,
  • Neomed Management AS,
  • Sunesis Pharmaceuticals Inc.,
  • Pfizer Inc.,
  • Bristol-Myers Squibb Company,
  • Novartis AG,
  • GlaxoSmithKline plc.,

North America to Emerge Dominate in the Global Market

Geographically, the global acute myeloid leukemia treatment market is segmented into North America, Europe, Asia- Pacific, Latin America, Middle East & Africa. North America is expected to dominate the global acute myeloid leukemia treatment market during the forecast period. Strategic research and development, excellent health reimbursement policies along with growing demand for advanced treatment I are boosting the market in the region. In Europe, the acute myeloid leukemia treatment market is predicted to grow at a significant rate, owing to the rising incidence of disease and active government aid. The Asia Pacific market is expected to grow at a remarkable CAGR during the forecast period owing to the increasing government expenditure for the treatment of cancer and developing healthcare infrastructure. In addition, rising inclination towards targeted therapies is expected to boost the growth of the global acute myeloid leukemia treatment market in the region in the forthcoming year.

Global Acute Myeloid Leukemia Treatment Market Segmentation :

By Disease Type

  • Myeloblastic
  • Promyelocytic
  • Myelomonocytic
  • Others

By Treatment Type

  • Chemotherapy
  • Targeted Therapy
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Reasons to Purchase this Report:

  • Comprehensive analysis of the Acute Myeloid Leukemia Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Have Any Query? Ask Our Experts:


  • What are the key technological and Acute Myeloid Leukemia Treatment Market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?
  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the Acute Myeloid Leukemia Treatment Market growth?

More Trending Topics From Fortune Business [email protected]

Hearing Aids Market worth USD 13.38 Billion at 8.2% CAGR; High Demand for Less Noticeable Devices to Increase Aesthetic Appeal will Favor Hearing Aids Market Growth

Clear Aligners Market to Exhibit Stellar 19.7% CAGR by 2028 ;Backed by Increasing Demand for Orthodontics in North America

Recombinant Proteins Market to Exhibit Promising Growth Fueled by Rising Concerns regarding Prevalence of Chronic Diseases Worldwide, States Fortune Business Insights™

Softgel Capsules Market to Garner Considerable Momentum Owing to Large Presence of Geriatric Population Worldwide, reports Fortune Business Insights™

Vitamin Test Market to Maintain Steady Development; Rapidly Growing Pharmaceutical Industry in U.S. to Help North America Gain Dominant Share: Fortune Business Insights™

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *